Filing Details

Accession Number:
0001209191-22-051303
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-09-26 19:23:40
Reporting Period:
2022-09-22
Accepted Time:
2022-09-26 19:23:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
906709 Nektar Therapeutics NKTR Pharmaceutical Preparations (2834) 943134940
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1227886 Robert Chess C/O Nektar Therapeutics
455 Mission Bay Boulevard South
San Francisco CA 94158
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-09-22 5,100 $3.19 228,179 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,100 Indirect by daughter
Common Stock 2,100 Indirect by son
Common Stock 2,100 Indirect by daughter
Common Stock 28,794 Indirect by Robert Chess Grantor Retained Annuity Trust
Common Stock 28,000 Indirect by Stacey Chess Grantor Retained Annuity Trust
Footnotes
  1. This transaction was made pursuant to a Rule 10b5-1 trading plan.
  2. This transaction was executed in multiple trades at prices ranging from $3.13 to $3.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
  3. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.